Companies / BLS

BLS PHARMACEUTICALS LIMITED

ASX:BLSHousehold & Personal ProductsSuspended from quotation
230.0M shares on issueASX (delayed) · as of 28 July 2026$0.81price · delayed$193.2Mmarket cap · indicative
NR
Dilution grade

Not rated — the company is suspended from quotation

Cash runwayno data — suspended — grade not computed
Share-count growth (24m)no data — suspended — grade not computed
Raise cadence (24m)0 cash raises
Options & rights overhangno data
In-the-money supplyno data — no recent share price on record
Pending proposed issuesnone

BLS PHARMACEUTICALS LIMITED has no share-issuance Appendix 2A filings on record in the reporting window, so a share-count change series is not available. The company did not raise capital in the past 24 months. At the June 2026 quarter the company reported A$14.2M in available cash. There are no proposed securities issues (Appendix 3B) currently pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
0.0%
Max option dilution
0.0%
ITM option dilution
0
Raises · last 12 months
—
Cash cover

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 230.0M per ASX (delayed) (28 July 2026).
229.1M230.0M230.9MJuly 26July 26July 26

Cash runway

—
Cover not computed for the latest quarter.
$14.2M available cash at quarter ended 30 June 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 30 June 2026.
Join the waitlist

Issuance timeline

Latest 0 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

No issuance filings (Appendix 2A / 3G / 3H) on record.
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

No equity raises in the last 24 months.
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

No options or rights over unissued shares on record.

Director dealings

No director dealing notices (Appendix 3Y) on record.
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

26 July 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
21 July 2026Agreement with Trexapharm for Commercialisation of Trexavive
20 July 2026BLS Strengthens Gobal Psychedelic Medicines Platform

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.